Literature DB >> 21262953

Clinical features and successful management of suicidal digoxin toxicity without use of digoxin-specific antibody (Fab) fragments--is it possible?

Hossein Sanaei-Zadeh1, Zahra Valian, Nasim Zamani, Hoorvash Farajidana, Babak Mostafazadeh.   

Abstract

A retrospective study of 147 consecutive cases of suicidal digoxin poisoning was undertaken in order to determine the severity and outcome of toxicity without use of digoxin-specific Fab fragments. This study showed that suicidal digoxin poisoning in young patients is usually mild to moderate; even underlying cardiac disease and chronic use of digoxin has no effect on the severity of toxicity and incidence of lethal dysrhythmia in these cases. This type of toxicity responds appropriately to conventional treatment.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21262953     DOI: 10.1258/td.2010.100195

Source DB:  PubMed          Journal:  Trop Doct        ISSN: 0049-4755            Impact factor:   0.731


  2 in total

Review 1.  Pharmacological treatment of cardiac glycoside poisoning.

Authors:  Darren M Roberts; Gamini Gallapatthy; Asunga Dunuwille; Betty S Chan
Journal:  Br J Clin Pharmacol       Date:  2015-12-15       Impact factor: 4.335

2.  Severe suicidal digoxin toxicity managed with resin hemoperfusion: A case report.

Authors:  Deven Juneja; Omender Singh; Alka Bhasin; Manish Gupta; Sanjay Saxena; Archana Chaturvedi
Journal:  Indian J Crit Care Med       Date:  2012-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.